EUVIMEDEUVIMED entdecken
Crossref

Biliverdin alleviates cerebral ischemia-reperfusion injury by regulating the P4hb/MAPK/mTOR pathway to inhibit autophagy

Huan Jiang, Wenya Bai, Yuan Yang, Guilin Zhou, Junjie Li, Xuelian Li, Xiaohong Wan, Jianlin Shao

Cellular Signalling · 2025

DOI: 10.1016/j.cellsig.2025.111815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Huan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan Province, China. Hauptthemen laut MEDLINE: Autophagy, Reperfusion Injury, TOR Serine-Threonine Kinases, Biliverdine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Applied Basic Research Key Project of Yunnan Province, Kunming Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Biliverdin (BV) exhibits anti-inflammatory and antioxidative effects. Autophagy activation is crucial in the pathogenesis of cerebral ischemia-reperfusion injury (CIRI). This study aimed to investigate whether BV could ameliorate CIRI by regulating autophagy. METHODS: A middle cerebral artery occlusion-reperfusion (MCAO/R) model in Sprague-Dawley (SD) rats and an oxygen-glucose deprivation/reoxygenation (OGD/R) model in PC12 cells were employed to explore the neuroprotective effects of BV and its underlying mechanisms. In these rats, once BV was administered post-MCAO/R, its treatment efficacy and underlying mechanisms were evaluated through behavioral, morphological, and molecular analyses. Alternatively, for PC12 cells, following successful OGD/R modeling, BV, autophagy activator rapamycin, prolyl 4-hydroxylase beta (P4hb) knockdown or overexpression, and the specific inhibitors of three classic autophagy pathways were applied. Cell viability (using CCK8 assay), Calcein/PI staining, autophagosome staining (using MDC assay), reverse transcription quantitative polymerase chain reaction, and western blot were subsequently carried out to investigate the mechanisms by which BV ameliorates CIRI. RESULTS: BV alleviated CIRI by inhibiting autophagy. Further investigation suggested that BV downregulated P4hb expression. In vitro experiments showed that P4hb knockdown reduced autophagy in post-CIRI cells, while its overexpression reversed the effects of BV. Rescue experiments indicated that MAPK pathway inhibitors counteracted the effects of P4hb overexpression on autophagy post-CIRI. CONCLUSION: BV improves CIRI by regulating the P4hb/MAPK/mTOR signaling pathway to inhibit autophagy, offering a novel therapeutic strategy for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyReperfusion InjuryTOR Serine-Threonine KinasesBiliverdineBrain IschemiaMAP Kinase Signaling SystemProlyl HydroxylasesAnimalsRatsRats, Sprague-DawleyPC12 CellsMaleSignal TransductionInfarction, Middle Cerebral ArteryNeuroprotective Agents

Stichwörter der Autor:innen

AutophagyBiliverdinCerebral ischemia-reperfusion injuryMAPK/mTOR signaling pathwayOxygen-glucose deprivation/reoxygenation injuryProlyl 4-hydroxylase beta

Substanzen

TOR Serine-Threonine KinasesBiliverdinemTOR protein, ratNeuroprotective AgentsProlyl Hydroxylases

Autor:innen und Institutionen

  • Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan Province, China.
  • Department of Anesthesiology, Second Affiliated Hospital of Kunming Medical University, 650000 Kunming, Yunnan Province, China.
  • Department of Anesthesiology, Second Affiliated Hospital of Kunming Medical University, 650000 Kunming, Yunnan Province, China. Electronic address: 13888586162@163.com.
  • Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan Province, China. Electronic address: shaojianlin@kmmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Applied Basic Research Key Project of Yunnan Province
  • Kunming Medical University

Zitieren

APA

Jiang, H., Bai, W., Yang, Y., Zhou, G., Li, J., Li, X., Wan, X., & Shao, J. (2025). Biliverdin alleviates cerebral ischemia-reperfusion injury by regulating the P4hb/MAPK/mTOR pathway to inhibit autophagy. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.111815

Vancouver

Jiang H, Bai W, Yang Y, Zhou G, Li J, Li X, et al. Biliverdin alleviates cerebral ischemia-reperfusion injury by regulating the P4hb/MAPK/mTOR pathway to inhibit autophagy. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.111815

BibTeX
@article{Jiang2025,
  author = {Jiang, Huan and Bai, Wenya and Yang, Yuan and Zhou, Guilin and Li, Junjie and Li, Xuelian and Wan, Xiaohong and Shao, Jianlin},
  title = {Biliverdin alleviates cerebral ischemia-reperfusion injury by regulating the P4hb/MAPK/mTOR pathway to inhibit autophagy},
  journal = {Cellular Signalling},
  year = {2025},
  doi = {10.1016/j.cellsig.2025.111815}
}
Kostenlos starten →